Compare, Analyse Biocon with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs MYLAN (US) - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    MYLAN
EQUITY SHARE DATA
    BIOCON
Mar-19
MYLAN
Dec-18
BIOCON /
MYLAN
5-Yr Chart
Click to enlarge
High Rs7073,470-   
Low Rs5541,910-   
Sales per share (Unadj.) Rs91.91,596.7-  
Earnings per share (Unadj.) Rs16.743.4-  
Cash flow per share (Unadj.) Rs24.2342.3-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs101.61,727.4-  
Shares outstanding (eoy) m600.00514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.91.7 407.2%   
Avg P/E ratio x37.762.0 60.8%  
P/CF ratio (eoy) x26.17.9 331.9%  
Price / Book Value ratio x6.21.6 398.4%  
Dividend payout %6.00-   
Avg Mkt Cap Rs m378,3301,384,010 27.3%   
No. of employees `0006.135.0 17.5%   
Total wages/salary Rs m11,6530-   
Avg. sales/employee Rs Th8,994.323,471.7 38.3%   
Avg. wages/employee Rs Th1,900.70-   
Avg. net profit/employee Rs Th1,635.3637.4 256.6%   
INCOME DATA
Net Sales Rs m55,144821,510 6.7%  
Other income Rs m1,4440-   
Total revenues Rs m56,588821,510 6.9%   
Gross profit Rs m15,883212,576 7.5%  
Depreciation Rs m4,478153,819 2.9%   
Interest Rs m70939,512 1.8%   
Profit before tax Rs m12,14019,246 63.1%   
Minority Interest Rs m90-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123-3,062 -69.3%   
Profit after tax Rs m10,02622,307 44.9%  
Gross profit margin %28.825.9 111.3%  
Effective tax rate %17.5-15.9 -109.9%   
Net profit margin %18.22.7 669.6%  
BALANCE SHEET DATA
Current assets Rs m48,228458,731 10.5%   
Current liabilities Rs m30,376334,465 9.1%   
Net working cap to sales %32.415.1 214.0%  
Current ratio x1.61.4 115.8%  
Inventory Days Days6884 81.7%  
Debtors Days Days8693 91.6%  
Net fixed assets Rs m64,130159,359 40.2%   
Share capital Rs m3,000437 685.9%   
"Free" reserves Rs m57,9800-   
Net worth Rs m60,980888,724 6.9%   
Long term debt Rs m15,766959,218 1.6%   
Total assets Rs m121,9242,383,903 5.1%  
Interest coverage x18.11.5 1,218.7%   
Debt to equity ratio x0.31.1 24.0%  
Sales to assets ratio x0.50.3 131.2%   
Return on assets %8.82.6 339.5%  
Return on equity %16.42.5 655.0%  
Return on capital %16.83.2 526.9%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Net fx Rs m5,1070-   
CASH FLOW
From Operations Rs m11,546170,710 6.8%  
From Investments Rs m-7,138-88,238 8.1%  
From Financial Activity Rs m-2,417-79,527 3.0%  
Net Cashflow Rs m2,1031,414 148.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 72.9 Rs / USD

Compare BIOCON With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare BIOCON With: ORCHID PHARMA  J.B.CHEMICALS  ELDER PHARMA  NEULAND LABS  STERLING BIOTECH  



Today's Market

Sensex Trades Marginally Lower; Dow Futures Down by 39 Points(12:30 pm)

Share markets in India are presently trading marginally lower. The BSE Sensex is trading down by 160 points, down 0.3% at 50,685 levels.

Related Views On News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

How Much Money For Day Trading? (Fast Profits Daily)

Feb 22, 2021

In this video, I'll show you how to allocate your capital as a day trader.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

BIOCON SHARE PRICE


Mar 5, 2021 03:32 PM

TRACK BIOCON

MORE ON BIOCON

BIOCON 8-QTR ANALYSIS

COMPARE BIOCON WITH

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

More Featured Videos

MARKET STATS